NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential

N **e, L Zhang, W Gao, C Huang, PE Huber… - Signal transduction and …, 2020 - nature.com
Nicotinamide adenine dinucleotide (NAD+) and its metabolites function as critical regulators
to maintain physiologic processes, enabling the plastic cells to adapt to environmental …

NAD+ in brain aging and neurodegenerative disorders

S Lautrup, DA Sinclair, MP Mattson, EF Fang - Cell metabolism, 2019 - cell.com
NAD+ is a pivotal metabolite involved in cellular bioenergetics, genomic stability,
mitochondrial homeostasis, adaptive stress responses, and cell survival. Multiple NAD+ …

Mitophagy and Alzheimer's disease: cellular and molecular mechanisms

JS Kerr, BA Adriaanse, NH Greig, MP Mattson… - Trends in …, 2017 - cell.com
Neurons affected in Alzheimer's disease (AD) experience mitochondrial dysfunction and a
bioenergetic deficit that occurs early and promotes the disease-defining amyloid beta …

NAD+ supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency

Y Hou, S Lautrup, S Cordonnier, Y Wang… - Proceedings of the …, 2018 - pnas.org
Emerging findings suggest that compromised cellular bioenergetics and DNA repair
contribute to the pathogenesis of Alzheimer's disease (AD), but their role in disease-defining …

[HTML][HTML] Nicotinamide riboside—the current state of research and therapeutic uses

M Mehmel, N Jovanović, U Spitz - Nutrients, 2020 - mdpi.com
Nicotinamide riboside (NR) has recently become one of the most studied nicotinamide
adenine dinucleotide (NAD+) precursors, due to its numerous potential health benefits …

Alzheimer's disease pathogenesis: Role of autophagy and mitophagy focusing in microglia

M Eshraghi, A Adlimoghaddam… - International Journal of …, 2021 - mdpi.com
Alzheimer's disease (AD) is a debilitating neurological disorder, and currently, there is no
cure for it. Several pathologic alterations have been described in the brain of AD patients …

Myelin in Alzheimer's disease: culprit or bystander?

M Maitre, H Jeltsch-David, NG Okechukwu… - Acta Neuropathologica …, 2023 - Springer
Alzheimer's disease (AD) is a neurodegenerative disorder with neuronal and synaptic
losses due to the accumulation of toxic amyloid β (Αβ) peptide oligomers, plaques, and …

Early neuronal accumulation of DNA double strand breaks in Alzheimer's disease

NM Shanbhag, MD Evans, W Mao, AL Nana… - Acta neuropathologica …, 2019 - Springer
The maintenance of genomic integrity is essential for normal cellular functions. However, it is
difficult to maintain over a lifetime in postmitotic cells such as neurons, in which DNA …

The role of PARP1 in neurodegenerative diseases and aging

K Mao, G Zhang - The FEBS journal, 2022 - Wiley Online Library
Neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease
(PD), are characterized by progressive memory loss and motor impairment. Aging is a major …

XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia

NC Hoch, H Hanzlikova, SL Rulten, M Tétreault… - Nature, 2017 - nature.com
XRCC1 is a molecular scaffold protein that assembles multi-protein complexes involved in
DNA single-strand break repair,. Here we show that biallelic mutations in the human XRCC1 …